These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1437229)

  • 1. On the interaction between macrophages and developmental stages of Schistosoma mansoni: effect of muramyl tripeptide phosphatidyl ethanolamine (MTP-PE) treatment on mice survival and the generation of schistosomulicidal macrophages.
    Seger M; Gold D; Lengy J; Pauli H; Keisari Y
    Parasite Immunol; 1992 Jul; 14(4):355-69. PubMed ID: 1437229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The schistosomulicidal activity and the production of IL-1 and TNF-alpha by peritoneal macrophages from infected mice and their potentiation by muramyl tripeptide-phosphatidyl ethanolamine (MTP-PE) treatment.
    Seger M; Gold D; Lengy J; Pauli H; Keisari Y
    Parasite Immunol; 1993 Jun; 15(6):339-47. PubMed ID: 8361776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-1, TNF-alpha and IL-2 production by peritoneal and spleen cells from Schistosoma mansoni infected mice and its potentiation by preimmunization with schistosomal antigens and immunostimulants.
    Keisari Y; Seger M; Lengy J; Pauli H; Nathan E; Gold D
    Immunobiology; 1993 Aug; 188(4-5):446-59. PubMed ID: 8244448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The interactions between macrophages and developmental stages of Schistosoma mansoni: effect of macrophage function modulators on the viability of S. mansoni in vivo and in vitro.
    Malkin R; Flescher E; Lengy J; Keisari Y
    J Biol Response Mod; 1986 Oct; 5(5):470-80. PubMed ID: 3095497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of rat Kupffer cells to tumoricidal cells by the immunomodulator muramyl tripeptide-phosphatidylethanolamine incorporated into the novel drug carrier lactosylated low density lipoprotein.
    van de Water B; van Berkel TJ; Kuiper J
    Mol Pharmacol; 1994 May; 45(5):971-7. PubMed ID: 8190111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional muramyl tripeptide phosphatidylethanolamine administration enhances hepatic immune function and tumor surveillance.
    Karpoff HM; Jarnagin W; Delman K; Fong Y
    Surgery; 2000 Aug; 128(2):213-8. PubMed ID: 10922994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the interactions between macrophages and developmental stages of Schistosoma mansoni: the cytotoxic mechanisms involved in macrophage-mediated killing of schistosomula in vitro.
    Malkin R; Flescher E; Lengy J; Keisari Y
    Immunobiology; 1987 Dec; 176(1-2):63-72. PubMed ID: 2834289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Schistosoma mansoni in mice: the pattern of primary cercarial exposure determines whether a secondary infection post-chemotherapy elicits a T helper 1- or a T helper 2-associated immune response.
    Farah IO; Johansson M; Lövgren-Bengtson K; Hau J
    Scand J Immunol; 2000 Mar; 51(3):237-43. PubMed ID: 10736092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic activation of tumoricidal properties in mouse macrophages and inhibition of melanoma metastases by the oral administration of MTP-PE, a lipophilic muramyl dipeptide.
    Fidler IJ; Fogler WE; Brownbill AF; Schumann G
    J Immunol; 1987 Jun; 138(12):4509-14. PubMed ID: 3584979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liposomal muramyl tripeptide phosphatidylethanolamine: Targeting and activating macrophages for adjuvant treatment of osteosarcoma.
    Nardin A; Lefebvre ML; Labroquère K; Faure O; Abastado JP
    Curr Cancer Drug Targets; 2006 Mar; 6(2):123-33. PubMed ID: 16529542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liposome-encapsulated MTP-PE: a novel biologic agent for cancer therapy.
    Asano T; Kleinerman ES
    J Immunother Emphasis Tumor Immunol; 1993 Nov; 14(4):286-92. PubMed ID: 8280710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biologic therapy for osteosarcoma using liposome-encapsulated muramyl tripeptide.
    Kleinerman ES
    Hematol Oncol Clin North Am; 1995 Aug; 9(4):927-38. PubMed ID: 7490249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of host resistance against virus infections by MTP-PE, a synthetic lipophilic muramyl peptide--I. Increased survival in mice and guinea pigs after single drug administration prior to infection, and the effect of MTP-PE on interferon levels in sera and lungs.
    Dietrich FM; Hochkeppel HK; Lukas B
    Int J Immunopharmacol; 1986; 8(8):931-42. PubMed ID: 2433236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined modality radioprotection: enhancement of survival and hematopoietic recovery in gamma-irradiated mice by the joint use of liposomal muramyl tripeptide phosphatidylethanolamine (MTP-PE) and indomethacin.
    Fedorocko P; Macková NO
    Int J Immunopharmacol; 1996 May; 18(5):329-37. PubMed ID: 8933212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liposomal muramyl tripeptide phosphatidylethanolamine (MTP-PE) promotes haemopoietic recovery in irradiated mouse.
    Fedorocko P
    Int J Radiat Biol; 1994 Apr; 65(4):465-75. PubMed ID: 7908934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative interaction of free and liposome-encapsulated nor-muramyl dipeptide or muramyl tripeptide phosphatidylethanolamine (3H-labelled) with human blood monocytes.
    Fogler WE; Fidler IJ
    Int J Immunopharmacol; 1987; 9(2):141-50. PubMed ID: 3583507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mifamurtide: CGP 19835, CGP 19835A, L-MTP-PE, liposomal MTP-PE, MLV 19835A, MTP-PE, muramyltripeptide phosphatidylethanolamine.
    Drugs R D; 2008; 9(2):131-5. PubMed ID: 18298131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The lipophilic muramyltripeptide MTP-PE, a biological response modifier, is an activator of protein kinase C.
    Meyer T; Fabbro D; Eppenberger U; Matter A
    Biochem Biophys Res Commun; 1986 Nov; 140(3):1043-50. PubMed ID: 3465326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Liposome-Entrapped Muramyl Tripeptide Phosphatidylethanolamine (L-MTP-PE) on the Tumor Growth and Survival of Mice Bearing Syngeneic Tumor in Combination with a Chemotherapeutic or Immunomodulatory Agent.
    Tanaka M; Abe S
    Drug Res (Stuttg); 2022 Sep; 72(7):372-377. PubMed ID: 35767993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [L-MTP-PE--a potential antineoplastic agent].
    Dzierzbicka K; Gozdowska M; Kołodziejczyk AM
    Postepy Hig Med Dosw; 1997; 51(2):227-36. PubMed ID: 9235567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.